Finally we concluded that our results are in favor with targeting the PD-1/PD-L1 pathway as route for immunotherapy in colorectal cancer, where, PD-L1 expression was detected in both tumor cells and lymphocytes. This evidence concerns the gene CD274 and neoplasm.